Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Drugs for treating severe hypertension in pregnancy: a network meta‐analysis and trial sequential analysis of randomized clinical trialsBritish journal of clinical pharmacology, 2018-09, Vol.84 (9), p.1906-1916 [Peer Reviewed Journal]2018 The British Pharmacological Society ;2018 The British Pharmacological Society. ;ISSN: 0306-5251 ;EISSN: 1365-2125 ;DOI: 10.1111/bcp.13649 ;PMID: 29974489Full text available |
|
2 |
Material Type: Article
|
Drug-induced systemic lupus: revisiting the ever-changing spectrum of the disease using the WHO pharmacovigilance databaseAnnals of the rheumatic diseases, 2019-04, Vol.78 (4), p.504-508 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ. ;2019 Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2018-214598 ;PMID: 30793701Full text available |
|
3 |
Material Type: Article
|
Combination of Isosorbide Dinitrate and Hydralazine in Blacks with Heart FailureThe New England journal of medicine, 2004-11, Vol.351 (20), p.2049-2057 [Peer Reviewed Journal]Copyright © 2004 Massachusetts Medical Society. All rights reserved. ;2004 INIST-CNRS ;Copyright 2004 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa042934 ;PMID: 15533851 ;CODEN: NEJMAGFull text available |
|
4 |
Material Type: Article
|
The Effects of Verapamil, Hydralazine, and Doxazosin on Renin, Aldosterone, and the Ratio ThereofCardiovascular drugs and therapy, 2023-04, Vol.37 (2), p.283-289 [Peer Reviewed Journal]The Author(s) 2021 ;2021. The Author(s). ;The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0920-3206 ;EISSN: 1573-7241 ;DOI: 10.1007/s10557-021-07262-3 ;PMID: 34515895Full text available |
|
5 |
Material Type: Article
|
A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumorsAnnals of oncology, 2007-09, Vol.18 (9), p.1529-1538 [Peer Reviewed Journal]2007 European Society for Medical Oncology 2007 ;2007 INIST-CNRS ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdm204 ;PMID: 17761710Full text available |
|
6 |
Material Type: Article
|
Neonatal hypertension: cases, causes, and clinical approachPediatric nephrology (Berlin, West), 2019-05, Vol.34 (5), p.787-799 [Peer Reviewed Journal]IPNA 2018 ;COPYRIGHT 2019 Springer ;Pediatric Nephrology is a copyright of Springer, (2018). All Rights Reserved. ;ISSN: 0931-041X ;EISSN: 1432-198X ;DOI: 10.1007/s00467-018-3977-4 ;PMID: 29808264Full text available |
|
7 |
Material Type: Article
|
Hydralazine induced lupus nephritis after prolonged exposureThe American journal of the medical sciences, 2021-01, Vol.361 (1), p.130-131 [Peer Reviewed Journal]2020 Southern Society for Clinical Investigation ;ISSN: 0002-9629 ;EISSN: 1538-2990 ;DOI: 10.1016/j.amjms.2020.07.007 ;PMID: 32732074Full text available |
|
8 |
Material Type: Article
|
Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational studyThe Lancet (British edition), 2003-03, Vol.361 (9363), p.1077-1083 [Peer Reviewed Journal]2003 Elsevier Ltd ;2003 INIST-CNRS ;Copyright Lancet Ltd. Mar 29, 2003 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(03)12892-9 ;PMID: 12672310 ;CODEN: LANCAOFull text available |
|
9 |
Material Type: Article
|
Hydralazine-Induced Fulminant Liver Failure Requiring Urgent Liver Transplant: Common Drug With Rare ComplicationExperimental and clinical transplantation, 2023-01, Vol.21 (1), p.55-58 [Peer Reviewed Journal]ISSN: 1304-0855 ;EISSN: 2146-8427 ;DOI: 10.6002/ect.2021.0446Full text available |
|
10 |
Material Type: Article
|
Drug-induced lupus: an update on its dermatologic aspectsLupus, 2009-10, Vol.18 (11), p.935-940 [Peer Reviewed Journal]ISSN: 0961-2033 ;EISSN: 1477-0962 ;DOI: 10.1177/0961203309106176 ;PMID: 19762393Full text available |
|
11 |
Material Type: Article
|
Clinical Effectiveness of Hydralazine-Isosorbide Dinitrate Therapy in Patients With Heart Failure and Reduced Ejection Fraction: Findings From the Get With The Guidelines-Heart Failure RegistryCirculation. Heart failure, 2016-02, Vol.9 (2), p.e002444-e002444 [Peer Reviewed Journal]2016 American Heart Association, Inc. ;ISSN: 1941-3289 ;EISSN: 1941-3297 ;DOI: 10.1161/CIRCHEARTFAILURE.115.002444 ;PMID: 26867758Full text available |
|
12 |
Material Type: Article
|
Diagnostic dilemma: drug-induced vasculitis versus systemic vasculitisBMJ case reports, 2023-07, Vol.16 (7), p.e254736 [Peer Reviewed Journal]BMJ Publishing Group Limited 2023. No commercial re-use. See rights and permissions. Published by BMJ. ;2023 BMJ Publishing Group Limited 2023. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1757-790X ;EISSN: 1757-790X ;DOI: 10.1136/bcr-2023-254736 ;PMID: 37429646Full text available |
|
13 |
Material Type: Article
|
Hydralazine-associated adverse events: a report of two cases of hydralazine-induced ANCA vasculitisBrazilian Journal of Nephrology, 2018-04, Vol.40 (2), p.193-197 [Peer Reviewed Journal]This work is licensed under a Creative Commons Attribution 4.0 International License. ;ISSN: 0101-2800 ;ISSN: 2175-8239 ;EISSN: 2175-8239 ;DOI: 10.1590/2175-8239-jbn-3858 ;PMID: 29738027Full text available |
|
14 |
Material Type: Article
|
Hydralazine-Induced ANCA Associated Vasculitis (AAV) Presenting with Pulmonary-Renal Syndrome (PRS): A Case Report with Literature ReviewCurrent cardiology reviews, 2021, Vol.17 (2), p.182-187 [Peer Reviewed Journal]Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net. ;Copyright Bentham Science Mar 2021 ;2021 Bentham Science Publishers 2021 ;ISSN: 1573-403X ;EISSN: 1875-6557 ;DOI: 10.2174/1573403X16666200518092814 ;PMID: 32418528Full text available |
|
15 |
Material Type: Article
|
Drug-induced lupus erythematosusArchives of Dermatological Research, 2009, Vol.301 (1), p.99-105 [Peer Reviewed Journal]Springer-Verlag 2008 ;2009 INIST-CNRS ;Springer-Verlag 2009 ;ISSN: 0340-3696 ;EISSN: 1432-069X ;DOI: 10.1007/s00403-008-0895-5 ;PMID: 18797892 ;CODEN: ADREDLFull text available |
|
16 |
Material Type: Article
|
Hydralazine-induced antineutrophil cytoplasmic antibody-associated vasculitis with pulmonary-renal syndrome: a case reportJournal of medical case reports, 2020-04, Vol.14 (1), p.47-5, Article 47 [Peer Reviewed Journal]COPYRIGHT 2020 BioMed Central Ltd. ;COPYRIGHT 2020 BioMed Central Ltd. ;2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 1752-1947 ;EISSN: 1752-1947 ;DOI: 10.1186/s13256-020-02378-w ;PMID: 32290867Full text available |
|
17 |
Material Type: Article
|
Severe cutaneous presentation of hydralazine-induced ANCA vasculitis without renal or pulmonary involvement, complicated by DICBMJ case reports, 2021-05, Vol.14 (5), p.e238609 [Peer Reviewed Journal]BMJ Publishing Group Limited 2021. No commercial re-use. See rights and permissions. Published by BMJ. ;BMJ Publishing Group Limited 2021. No commercial re-use. See rights and permissions. Published by BMJ. 2021 ;ISSN: 1757-790X ;EISSN: 1757-790X ;DOI: 10.1136/bcr-2020-238609 ;PMID: 33975832Full text available |
|
18 |
Material Type: Article
|
Successful use of rituximab for hydralazine-induced anti-neutrophil cytoplasmic antibodies-associated vasculitisSaudi journal of kidney diseases and transplantation, 2019-01, Vol.30 (1), p.226-230 [Peer Reviewed Journal]2019. This work is published under https://creativecommons.org/licenses/by-nc-sa/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1319-2442 ;EISSN: 2320-3838 ;DOI: 10.4103/1319-2442.252915 ;PMID: 30804286Full text available |
|
19 |
Material Type: Article
|
Combination Hydralazine and Isosorbide Dinitrate in Dialysis-Dependent ESRD (HIDE): A Randomized, Placebo-Controlled, Pilot TrialKidney360, 2020-12, Vol.1 (12), p.1380-1389 [Peer Reviewed Journal]Copyright © 2020 by the American Society of Nephrology. ;Copyright © 2020 by the American Society of Nephrology 2020 ;ISSN: 2641-7650 ;EISSN: 2641-7650 ;DOI: 10.34067/KID.0004342020 ;PMID: 35372900Full text available |
|
20 |
Material Type: Article
|
Hydralazine-induced lupus syndrome presenting with large pericardial effusionQJM : An International Journal of Medicine, 2014-04, Vol.107 (4), p.305-307 [Peer Reviewed Journal]ISSN: 1460-2725 ;EISSN: 1460-2393 ;DOI: 10.1093/qjmed/hct223 ;PMID: 24194564Full text available |